RESUMEN
BACKGROUND: The use of radiofrequency identification (RFID) systems is expanding and highlights the need to address electromagnetic interference (EMI) to implantable pacemakers and implantable cardioverter-defibrillators (ICDs). OBJECTIVE: This study sought to examine the electromagnetic compatibility (EMC) between RFID readers and implantable pacemakers or ICDs. METHODS: During in vitro testing, 15 implantable pacemakers and 15 ICDs were exposed to 13 passive RFID readers in 3 frequency bands: 134 kHz (low frequency [LF]), 13.56 MHz (high frequency [HF]), and 915 MHz (ultra high frequency [UHF]). RESULTS: While being exposed to LF RFID, a reaction was observed for 67% of all pacemaker tests (maximum distance 60 cm) and 47% of all ICD tests (maximum distance 40 cm). During HF RFID exposure, a reaction was observed for 6% of all pacemaker tests (maximum distance 22.5 cm) and 1% of all ICD tests (maximum distance 7.5 cm). For both pacemakers and ICDs, no reactions were observed during exposure to UHF RFID or continuous-wave RFID. Pacemakers and ICDs were most susceptible to modulated LF RFID readers. CONCLUSION: Although there is in vitro testing evidence for concern for implantable pacemaker and ICD EMI at LF and HF, the FDA has not received any incident reports of pacemaker or ICD EMI caused by any RFID system. We do not believe the current situation reveals an urgent public health risk.
Asunto(s)
Desfibriladores Implantables/normas , Campos Electromagnéticos/efectos adversos , Marcapaso Artificial/normas , Dispositivo de Identificación por Radiofrecuencia/normas , Desfibriladores Implantables/efectos adversos , Falla de Equipo , Seguridad de Equipos , Humanos , Marcapaso Artificial/efectos adversos , Fantasmas de Imagen , Proyectos Piloto , Medición de Riesgo , Factores de RiesgoRESUMEN
PURPOSE: To prospectively measure the response of a variety of models of implantable cardiac rhythm management devices (ICRMDs) to the radiation delivered by computed tomography (CT), for both maximum and typical dose levels. MATERIALS AND METHODS: Twenty-one ICRMDs (13 pacemakers, eight cardioverter-defibrillators) manufactured by Medtronic (Minneapolis, Minn) were exposed to ionizing radiation from CT systems in both spiral and dynamic acquisition modes at maximum and typical dose levels. Devices were monitored during exposure to check for any operational abnormalities and were interrogated after exposure to check for any residual abnormalities. Total radiation dose and peak dose rate were measured, and the volume CT dose index was recorded. RESULTS: Oversensing was observed in 20 of 21 devices at maximum doses and in 17 of 20 devices at typical doses. Oversensing most often manifested as inhibition, although it occasionally manifested as tracking or safety pacing. Two devices inhibited for more than 4 seconds in spiral mode at clinical dose levels. Oversensing was transient and ceased as soon as the device stopped moving through the x-ray beam or the beam was turned off. The partial electrical reset (PER) safety feature was activated in two models, InSync 8040 and Thera DR. With the exception of PER, programming was not altered. Effects occurred only if the x-ray beam passed directly over the ICRMD. CONCLUSION: CT irradiation at typical clinical doses results in oversensing of ICRMDs in the majority of devices tested, although the identified effects were predominantly transient.